DP

Dasari Parameshwar

Active Director Designated Partner DIN 10998527
DIN 10998527 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dasari Parameshwar

Data last updated:

Dasari Parameshwar is a Designated Partner at Arwilda Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 10998527
Primary Designation Designated Partner
Industry Pharma
First Appointment 12 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Mar 20252025Active

Board colleagues of Dasari Parameshwar

NameDINCompanyDesignation
Dasari Balaswamy10998528Arwilda Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Arwilda Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Dasari Parameshwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dasari Parameshwar

Dasari Parameshwar currently holds 1 directorship: Arwilda Pharmaceuticals Llp (Designated Partner, since 12 Mar 2025).

Dasari Parameshwar was first appointed on 12 Mar 2025 as Designated Partner at Arwilda Pharmaceuticals Llp.

The current boards of Dasari Parameshwar's companies include Dasari Balaswamy (Arwilda Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available